Irwin Matyjaszczyk holds a PhD in molecular biology from the University of Wroclaw. He spent six years at Pure Biologics, where he was responsible for antibody discovery and optimization as well as method development in projects that progressed to clinical research. In 2024, he joined Selvita, where he contributes to the advancement of phage display technology through the design of phage display libraries, development of novel selection methodologies, and application of NGS-driven data analysis.